 | • レポートコード：MRC309Z7859 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の凍結乾燥ヒト狂犬病ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の凍結乾燥ヒト狂犬病ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 凍結乾燥ヒト狂犬病ワクチンの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 凍結乾燥ヒト狂犬病ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・ベロ細胞、ヒト二倍体細胞、その他 用途別セグメント ・病院、診療所 主要な市場プレーヤー ・Sanofi Pasteur SA、Guangzhou Nuocheng、Ningbo Rong'an、Hualan Bio-vaccine、Bharat Biotech、Bavarian Nordic、Serum Institute of India Pvt.、Chengdu Kanghua Biology、Changchun Zhuoyi Biology、Dalian Yali Peak 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、凍結乾燥ヒト狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な凍結乾燥ヒト狂犬病ワクチンメーカーの企業概要、2019年～2022年までの凍結乾燥ヒト狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な凍結乾燥ヒト狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別凍結乾燥ヒト狂犬病ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの凍結乾燥ヒト狂犬病ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での凍結乾燥ヒト狂犬病ワクチン市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および凍結乾燥ヒト狂犬病ワクチンの産業チェーンを掲載しています。 ・第14、15章では、凍結乾燥ヒト狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 凍結乾燥ヒト狂犬病ワクチンの概要 - 種類別分析（2018年vs2022年vs2029年）：ベロ細胞、ヒト二倍体細胞、その他 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所 - 世界の凍結乾燥ヒト狂犬病ワクチン市場規模・予測 - 世界の凍結乾燥ヒト狂犬病ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Sanofi Pasteur SA、Guangzhou Nuocheng、Ningbo Rong'an、Hualan Bio-vaccine、Bharat Biotech、Bavarian Nordic、Serum Institute of India Pvt.、Chengdu Kanghua Biology、Changchun Zhuoyi Biology、Dalian Yali Peak ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：ベロ細胞、ヒト二倍体細胞、その他 ・用途別分析2018年-2029年：病院、診療所 ・凍結乾燥ヒト狂犬病ワクチンの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・凍結乾燥ヒト狂犬病ワクチンのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・凍結乾燥ヒト狂犬病ワクチンのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・凍結乾燥ヒト狂犬病ワクチンの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・凍結乾燥ヒト狂犬病ワクチンの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Freeze-dried Human Rabies Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report is a detailed and comprehensive analysis for global Freeze-dried Human Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Freeze-dried Human Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Freeze-dried Human Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Freeze-dried Human Rabies Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Freeze-dried Human Rabies Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur SA, Guangzhou Nuocheng, Ningbo Rong’an, Hualan Bio-vaccine and Bharat Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Freeze-dried Human Rabies Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vero Cells
Human Diploid Cells
Other
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi Pasteur SA
Guangzhou Nuocheng
Ningbo Rong’an
Hualan Bio-vaccine
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Freeze-dried Human Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Freeze-dried Human Rabies Vaccine, with price, sales, revenue and global market share of Freeze-dried Human Rabies Vaccine from 2018 to 2023.
Chapter 3, the Freeze-dried Human Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Freeze-dried Human Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Freeze-dried Human Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Freeze-dried Human Rabies Vaccine.
Chapter 14 and 15, to describe Freeze-dried Human Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Freeze-dried Human Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Freeze-dried Human Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vero Cells
1.3.3 Human Diploid Cells
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Freeze-dried Human Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Freeze-dried Human Rabies Vaccine Market Size & Forecast
1.5.1 Global Freeze-dried Human Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Freeze-dried Human Rabies Vaccine Sales Quantity (2018-2029)
1.5.3 Global Freeze-dried Human Rabies Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur SA
2.1.1 Sanofi Pasteur SA Details
2.1.2 Sanofi Pasteur SA Major Business
2.1.3 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Product and Services
2.1.4 Sanofi Pasteur SA Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur SA Recent Developments/Updates
2.2 Guangzhou Nuocheng
2.2.1 Guangzhou Nuocheng Details
2.2.2 Guangzhou Nuocheng Major Business
2.2.3 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Product and Services
2.2.4 Guangzhou Nuocheng Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guangzhou Nuocheng Recent Developments/Updates
2.3 Ningbo Rong’an
2.3.1 Ningbo Rong’an Details
2.3.2 Ningbo Rong’an Major Business
2.3.3 Ningbo Rong’an Freeze-dried Human Rabies Vaccine Product and Services
2.3.4 Ningbo Rong’an Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Ningbo Rong’an Recent Developments/Updates
2.4 Hualan Bio-vaccine
2.4.1 Hualan Bio-vaccine Details
2.4.2 Hualan Bio-vaccine Major Business
2.4.3 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Product and Services
2.4.4 Hualan Bio-vaccine Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hualan Bio-vaccine Recent Developments/Updates
2.5 Bharat Biotech
2.5.1 Bharat Biotech Details
2.5.2 Bharat Biotech Major Business
2.5.3 Bharat Biotech Freeze-dried Human Rabies Vaccine Product and Services
2.5.4 Bharat Biotech Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bharat Biotech Recent Developments/Updates
2.6 Bavarian Nordic
2.6.1 Bavarian Nordic Details
2.6.2 Bavarian Nordic Major Business
2.6.3 Bavarian Nordic Freeze-dried Human Rabies Vaccine Product and Services
2.6.4 Bavarian Nordic Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bavarian Nordic Recent Developments/Updates
2.7 Serum Institute of India Pvt.
2.7.1 Serum Institute of India Pvt. Details
2.7.2 Serum Institute of India Pvt. Major Business
2.7.3 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Product and Services
2.7.4 Serum Institute of India Pvt. Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Serum Institute of India Pvt. Recent Developments/Updates
2.8 Chengdu Kanghua Biology
2.8.1 Chengdu Kanghua Biology Details
2.8.2 Chengdu Kanghua Biology Major Business
2.8.3 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Product and Services
2.8.4 Chengdu Kanghua Biology Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chengdu Kanghua Biology Recent Developments/Updates
2.9 Changchun Zhuoyi Biology
2.9.1 Changchun Zhuoyi Biology Details
2.9.2 Changchun Zhuoyi Biology Major Business
2.9.3 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Product and Services
2.9.4 Changchun Zhuoyi Biology Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Changchun Zhuoyi Biology Recent Developments/Updates
2.10 Dalian Yali Peak
2.10.1 Dalian Yali Peak Details
2.10.2 Dalian Yali Peak Major Business
2.10.3 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Product and Services
2.10.4 Dalian Yali Peak Freeze-dried Human Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Dalian Yali Peak Recent Developments/Updates
3 Competitive Environment: Freeze-dried Human Rabies Vaccine by Manufacturer
3.1 Global Freeze-dried Human Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Freeze-dried Human Rabies Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Freeze-dried Human Rabies Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Freeze-dried Human Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Freeze-dried Human Rabies Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Freeze-dried Human Rabies Vaccine Manufacturer Market Share in 2022
3.5 Freeze-dried Human Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Freeze-dried Human Rabies Vaccine Market: Region Footprint
3.5.2 Freeze-dried Human Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Freeze-dried Human Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Freeze-dried Human Rabies Vaccine Market Size by Region
4.1.1 Global Freeze-dried Human Rabies Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Freeze-dried Human Rabies Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Freeze-dried Human Rabies Vaccine Average Price by Region (2018-2029)
4.2 North America Freeze-dried Human Rabies Vaccine Consumption Value (2018-2029)
4.3 Europe Freeze-dried Human Rabies Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Freeze-dried Human Rabies Vaccine Consumption Value (2018-2029)
4.5 South America Freeze-dried Human Rabies Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Freeze-dried Human Rabies Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Freeze-dried Human Rabies Vaccine Consumption Value by Type (2018-2029)
5.3 Global Freeze-dried Human Rabies Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Freeze-dried Human Rabies Vaccine Consumption Value by Application (2018-2029)
6.3 Global Freeze-dried Human Rabies Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Freeze-dried Human Rabies Vaccine Market Size by Country
7.3.1 North America Freeze-dried Human Rabies Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Freeze-dried Human Rabies Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Freeze-dried Human Rabies Vaccine Market Size by Country
8.3.1 Europe Freeze-dried Human Rabies Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Freeze-dried Human Rabies Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Freeze-dried Human Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Freeze-dried Human Rabies Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Freeze-dried Human Rabies Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Freeze-dried Human Rabies Vaccine Market Size by Country
10.3.1 South America Freeze-dried Human Rabies Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Freeze-dried Human Rabies Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Freeze-dried Human Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Freeze-dried Human Rabies Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Freeze-dried Human Rabies Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Freeze-dried Human Rabies Vaccine Market Drivers
12.2 Freeze-dried Human Rabies Vaccine Market Restraints
12.3 Freeze-dried Human Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Freeze-dried Human Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Freeze-dried Human Rabies Vaccine
13.3 Freeze-dried Human Rabies Vaccine Production Process
13.4 Freeze-dried Human Rabies Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Freeze-dried Human Rabies Vaccine Typical Distributors
14.3 Freeze-dried Human Rabies Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
